Millie
your market intelligence analyst
Search Results
Edit Save
3,518 results
Xconomy 02/25/2020 14:04
Skyhawk Therapeutics has appointed Terry Connolly to serve as its chief operating officer. He had spent the past year as the Waltham, MA, company’s chief business officer. Before joining Skyhawk, Connolly held multiple roles at Celgene. Skyhawk is developing small molecule drugs that correct errors in RNA splicing. The company’s preclinical pipeline includes one program […]
Xconomy 02/25/2020 13:54
Aurinia Pharmaceuticals (NASDAQ: AUPH) has named Max Colao to the newly created position of chief commercial officer. He joins Victoria, BC-based Aurinia from Abeona Therapeutics (NASDAQ: ABEO), where he was executive vice president, chief commercial officer, and head of business development. Colao’s experience also includes positions at Alexion Pharmaceuticals (NASDAQ: ALXN) and Amgen (NASDAQ: AMGN). […]
Xconomy 02/25/2020 11:13
Genentech is the latest company to enter a drug discovery partnership with Bicycle Therapeutics, adding a new alliance in cancer research for the clinical-stage biotech. Under an agreement announced Tuesday, Roche subsidiary Genentech is paying Bicycle (NASDAQ: BCYC) $30 million up front. As programs progress, Bicycle could earn up to $1.7 billion in total milestone […]
Xconomy 02/24/2020 19:54
As Esperion Therapeutics steered its cholesterol-lowering drug through clinical testing and regulatory review, CEO Tim Mayleben did something unusual for a pharmaceutical executive: he spoke openly about price. Specifically, he talked about how inexpensive the drug would be. As early as two years ago, Mayleben said an FDA-approved Esperion (NASDAQ: ESPR) drug would cost patients […]
Xconomy 02/20/2020 15:47
Precision oncology company Turning Point Therapeutics (NASDAQ: TPTX) on Thursday said it has appointed Siegfried Reich as executive vice president and chief scientific officer. Reich, whose new role starts March 2, was most recently senior vice president of research at another San Diego-based cancer drug developer, eFFECTOR Therapeutics, which he co-founded. Reich’s experience includes time […]
Xconomy 02/19/2020 18:30
Many companies are working to develop new drugs that target harmful proteins associated with neurodegenerative diseases. EnClear Therapies has raised a $10 million Series A round of financing from a syndicate of investors to advance a device that it says could help treat neurodegenerative diseases by filtering out such proteins from cerebral spinal fluid (CSF), […]
Xconomy 02/19/2020 17:38
Endo International’s search for retiring CEO Paul Campanelli’s successor is ending close to home. Dublin, Ireland-based Endo (NASDAQ: ENDP) announced Wednesday that Chief Financial Officer Blaise Coleman will become president and CEO starting March 6. He will also take a seat on Endo’s board of directors. Before joining Endo in 2015, Coleman held leadership roles […]
Xconomy 02/19/2020 14:58
Join Xconomy on April 29 at Takeda Pharmaceutical’s Boston location for the next in our Xcelerating Life Sciences event series: Biopharma’s Future in Digital Health. The half-day conference will bring together innovators, executives, rising pioneers, entrepreneurs, investors, and scientists to examine what’s fueling Boston’s biotech investment and partnership opportunities. As the nation’s largest biopharma cluster, […]
Xconomy 02/18/2020 18:25
Taylor Schreiber, chief scientific officer and co-founder of Shattuck Labs, has been promoted to CEO. He succeeds Josiah Hornblower, who will continue to advise Shattuck as executive chairman of the company’s board of directors. Founded in 2016, Austin, TX-based Shattuck is developing “fusion protein” therapies to treat cancer. The company’s most advanced program, SL-279252, is […]

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications